Who are Cellectar Biosciences, Inc.'s main suppliers?

Cellectar Biosciences, Inc. (CLRB) key suppliers include: CAMPUS-100-LLC, IONETIX-CORPORATION, NORTHSTAR-MEDICAL-RADIOISOTOPES, ATOMVIE, SPECTRONRX and 5 more. View the full supplier network at chainsifter.com/chain/CLRB.

Who are Cellectar Biosciences, Inc.'s major customers?

Cellectar Biosciences, Inc. (CLRB) key customers include: ORANY, ORANY, TLPPF, GLOBAL-DATA-RESEARCH-GROUP. View the full customer network at chainsifter.com/chain/CLRB.

What sector is Cellectar Biosciences, Inc. in?

Cellectar Biosciences, Inc. (CLRB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Cellectar Biosciences, Inc. Suppliers, Customers & Supply Chain (CLRB)

10Suppliers

4Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Cellectar Biosciences, Inc. (CLRB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships

4Distinct source URLs

9High confidence

0.793Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cellectar Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CAMPUS-100-LLC	CAMPUS-100-LLC	90%	Under the Second Amended HQ Lease, which was accounted for as a modification of the initial lease and went into effect upon the landlord’s delivery of the expanded space in March 2026, the Company wi…
IONETIX-CORPORATION	IONETIX-CORPORATION	90%	In December 2025, the Company announced a multi-year supply agreement with Ionetix Corporation for two critical alpha-emitting radioisotopes: Actinium-225 (Ac-225) and Astatine-211 (At-21).
NORTHSTAR-MEDICAL-RADIOISOTOPES	NORTHSTAR-MEDICAL-RADIOISOTOPES	90%	As it relates to CLR 121225, it was announced in late 2024 that the one of the sources for actinium would be Northstar Medical Radioisotopes.
ATOMVIE	ATOMVIE	80%	The finished PRCs are currently supplied by either AtomVie or SpectronRx.
SPECTRONRX	SPECTRONRX	80%	The finished PRCs are currently supplied by either AtomVie or SpectronRx.
KZIA	Kazia Therapeutics Limited	72%	Reciprocal relationship from KZIA graph: Reciprocal relationship from CLRB graph: Reciprocal relationship from KZIA graph: pate will be required to complete clinical development of a product candidat…
ORANY	ORANY	72%	we experience unanticipated problems with our products, we may be subject to penalties, we may be unable to generate revenue from the sale of such products, our potential for generating positive cash…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CLRB graph: we experience unanticipated problems with our products, we may be subject to penalties, we may be unable to generate…
TLPPF	TLPPF	72%	Reciprocal relationship from TLPPF graph: Reciprocal relationship from CLRB graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maxi…
TLX	Telix Pharmaceuticals Limited	72%	Reciprocal relationship from TLX graph: Reciprocal relationship from CLRB graph: Reciprocal relationship from TLX graph: her strengthens our supply chain, reducing environmental impact while maximizi…

Cellectar Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	o conduct clinical trials, including full or partial clinical holds on ongoing or planned trials; ● restrictions on product manufacturing processes; ● restrictions on the marketing of a product; ● re…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CLRB graph: o conduct clinical trials, including full or partial clinical holds on ongoing or planned trials; ● restrictions on …
TLPPF	TLPPF	72%	Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to se…
GLOBAL-DATA-RESEARCH-GROUP	GLOBAL-DATA-RESEARCH-GROUP	62%	f pediatric solid tumors. The American Cancer Society estimates that there will be 2,301 cases diagnosed in 2026. The median age at diagnosis is 16, and the median age of death is 18. We are focused …

Cellectar Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CLRB-DEBT-8697	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2023-12-31.
CLRB-DEBT	Debt stack $330,222	90%	Market cache reports total debt of $330,222.
CLRB-DEBT-8696	Warrants outstanding: 3032892	90%	xbrl warrant detail from xbrl 2026-03-31.

Cellectar Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cellectar Biosciences, Inc..

Cellectar Biosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
CLRB-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 19 tracked holders.

Cellectar Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LNTH	Lantheus Holdings, Inc.	100.00	2
CATX	Perspective Therapeutics, Inc.	100.00	2
RADX	Radiopharm Theranostics Limited	100.00	2
KZIA	Kazia Therapeutics Limited	100.00	1	['supplier']
DRTS	Alpha Tau Medical Ltd.	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
TLPPF	Telix Pharmaceuticals Ltd	100.00	1	['customer', 'supplier']
TLX	Telix Pharmaceuticals Limited	100.00	1	['supplier']
BSX	Boston Scientific Corporation	100.00	2
SNSE	Sensei Biotherapeutics, Inc.	100.00	2
JANX	Janux Therapeutics, Inc.	100.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
ASTLW	Algoma Steel Group Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2

Cellectar Biosciences, Inc. Supply Chain